SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318771-03-000002
Filing Date
2003-02-14
Accepted
2003-02-14 16:12:09
Documents
6
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 GENENTECH, INC. FORM 10-K FOR PERIOD ENDING 12/31/2002 dna-10k_2002.htm 10-K 1127974
3 BYLAWS OF GENENTECH, INC. dna-ex3_4.htm EX-3.4 40017
4 GENENTECH, INC. TAX REDUCTION INVESTMENT PLAN dna-ex10_5.htm EX-10.5 253173
5 AMENDED & RESTATED BACKUP FACILITY AGREEMENT & AMENDMENT TO OTHER OPERATIVE AGRE dna-ex10_16.htm EX-10.16 34731
6 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dna-ex23_1.htm EX-23.1 1593
7 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER & CHIEF FINANCIAL OFFICER dna-ex99_1.htm EX-99.1 4237
  Complete submission text file 0000318771-03-000002.txt   1464031
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-09813 | Film No.: 03568013
SIC: 2834 Pharmaceutical Preparations